位置:首页 > 蛋白库 > RN114_MOUSE
RN114_MOUSE
ID   RN114_MOUSE             Reviewed;         229 AA.
AC   Q9ET26; Q3UFU8; Q8K5A2;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   03-JUL-2003, sequence version 2.
DT   03-AUG-2022, entry version 155.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF114;
DE            EC=2.3.2.27 {ECO:0000250|UniProtKB:Q9Y508};
DE   AltName: Full=RING finger protein 114;
DE   AltName: Full=RING-type E3 ubiquitin transferase RNF114 {ECO:0000305};
DE   AltName: Full=Zinc finger protein 228;
DE   AltName: Full=Zinc finger protein 313;
GN   Name=Rnf114; Synonyms=Zfp228, Zfp313, Znf228, Znf313;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Kunming; TISSUE=Testis;
RA   Zhang S., Ma Y.-X., Xia Q., Xiao C., Zhang G.;
RT   "Cloning of mouse homolog of human zinc finger-like gene ZNF228 possibly
RT   associated with spermatogenesis.";
RL   Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Aorta, Bone marrow, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and FVB/N; TISSUE=Brain, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Heart, Kidney, Liver, Lung, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=28625874; DOI=10.1016/j.cyto.2017.05.002;
RA   Lin B., Ke Q., Li H., Pheifer N.S., Velliquette D.C., Leaman D.W.;
RT   "Negative regulation of the RLH signaling by the E3 ubiquitin ligase
RT   RNF114.";
RL   Cytokine 99:186-193(2017).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that promotes the ubiquitination
CC       of various substrates. In turn, participates in the regulation of many
CC       biological processes including cell cycle, apoptosis,
CC       osteoclastogenesis as well as innate or adaptive immunity. Acts as
CC       negative regulator of NF-kappa-B-dependent transcription by promoting
CC       the ubiquitination and stabilization of the NF-kappa-B inhibitor
CC       TNFAIP3. May promote the ubiquitination of TRAF6 as well. Acts also as
CC       a negative regulator of T-cell activation. Inhibits cellular dsRNA
CC       responses and interferon production by targeting MAVS component for
CC       proteasomal degradation. Ubiquitinates the CDK inhibitor CDKN1A leading
CC       to its degradationand probably also CDKN1B and CDKN1C. This activity
CC       stimulates cell cycle G1-to-S phase transition and suppresses cellular
CC       senescence. May play a role in spermatogenesis.
CC       {ECO:0000250|UniProtKB:Q9Y508}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000250|UniProtKB:Q9Y508};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000250|UniProtKB:Q9Y508}.
CC   -!- SUBUNIT: Interacts with XAF1, the interaction increases XAF1 stability
CC       and proapoptotic effects, and may regulate IFN signaling.
CC       {ECO:0000250|UniProtKB:Q9Y508}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9Y508}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9Y508}.
CC   -!- PTM: Autoubiquitinated. Polyubiquitinated in the presence of E2 enzymes
CC       UBE2D1, UBE2D2 and UBE2D3, but only monoubiquitinated in the presence
CC       of UBE2E1. {ECO:0000250|UniProtKB:Q9Y508}.
CC   -!- DISRUPTION PHENOTYPE: Mice show no significant difference of viral
CC       resistance or augmented antiviral responses compared to WT when both
CC       are infected with virus. {ECO:0000269|PubMed:28625874}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF282919; AAG01141.2; -; mRNA.
DR   EMBL; AF502145; AAM22210.1; -; mRNA.
DR   EMBL; AK088441; BAC40355.1; -; mRNA.
DR   EMBL; AK139030; BAE23870.1; -; mRNA.
DR   EMBL; AK148290; BAE28461.1; -; mRNA.
DR   EMBL; AK148392; BAE28527.1; -; mRNA.
DR   EMBL; AK150086; BAE29295.1; -; mRNA.
DR   EMBL; AK150263; BAE29420.1; -; mRNA.
DR   EMBL; AK152687; BAE31418.1; -; mRNA.
DR   EMBL; AK153452; BAE32006.1; -; mRNA.
DR   EMBL; AK159818; BAE35398.1; -; mRNA.
DR   EMBL; BC054416; AAH54416.1; -; mRNA.
DR   EMBL; BC085146; AAH85146.1; -; mRNA.
DR   CCDS; CCDS17101.1; -.
DR   RefSeq; NP_109668.2; NM_030743.5.
DR   RefSeq; XP_006500502.1; XM_006500439.1.
DR   AlphaFoldDB; Q9ET26; -.
DR   BioGRID; 219874; 7.
DR   STRING; 10090.ENSMUSP00000077197; -.
DR   iPTMnet; Q9ET26; -.
DR   PhosphoSitePlus; Q9ET26; -.
DR   REPRODUCTION-2DPAGE; Q9ET26; -.
DR   EPD; Q9ET26; -.
DR   MaxQB; Q9ET26; -.
DR   PaxDb; Q9ET26; -.
DR   PeptideAtlas; Q9ET26; -.
DR   PRIDE; Q9ET26; -.
DR   ProteomicsDB; 300525; -.
DR   Antibodypedia; 13722; 184 antibodies from 24 providers.
DR   DNASU; 81018; -.
DR   Ensembl; ENSMUST00000078050; ENSMUSP00000077197; ENSMUSG00000006418.
DR   Ensembl; ENSMUST00000109214; ENSMUSP00000104837; ENSMUSG00000006418.
DR   GeneID; 81018; -.
DR   KEGG; mmu:81018; -.
DR   UCSC; uc008nzv.1; mouse.
DR   CTD; 55905; -.
DR   MGI; MGI:1933159; Rnf114.
DR   VEuPathDB; HostDB:ENSMUSG00000006418; -.
DR   eggNOG; ENOG502QW3F; Eukaryota.
DR   GeneTree; ENSGT00950000182909; -.
DR   HOGENOM; CLU_092448_1_0_1; -.
DR   InParanoid; Q9ET26; -.
DR   OMA; DYIEEGV; -.
DR   OrthoDB; 1097558at2759; -.
DR   PhylomeDB; Q9ET26; -.
DR   TreeFam; TF331012; -.
DR   Reactome; R-MMU-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 81018; 3 hits in 72 CRISPR screens.
DR   ChiTaRS; Rnf114; mouse.
DR   PRO; PR:Q9ET26; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q9ET26; protein.
DR   Bgee; ENSMUSG00000006418; Expressed in animal zygote and 250 other tissues.
DR   ExpressionAtlas; Q9ET26; baseline and differential.
DR   Genevisible; Q9ET26; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0000209; P:protein polyubiquitination; IBA:GO_Central.
DR   GO; GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   CDD; cd16540; RING-HC_RNF114; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR008598; Di19_Zn-bd.
DR   InterPro; IPR042716; RNF114_RING-HC.
DR   InterPro; IPR034734; ZF_C2HC_RNF.
DR   InterPro; IPR027370; Znf-RING_LisH.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF05605; zf-Di19; 1.
DR   Pfam; PF13445; zf-RING_UBOX; 1.
DR   Pfam; PF18574; zf_C2HC_14; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00355; ZnF_C2H2; 2.
DR   PROSITE; PS51803; ZF_C2HC_RNF; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Developmental protein; Differentiation;
KW   Metal-binding; Nucleus; Reference proteome; Spermatogenesis; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..229
FT                   /note="E3 ubiquitin-protein ligase RNF114"
FT                   /id="PRO_0000056308"
FT   ZN_FING         30..69
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         92..111
FT                   /note="C2HC RNF-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01144"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         92
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01144"
FT   BINDING         95
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01144"
FT   BINDING         107
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01144"
FT   BINDING         111
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01144"
FT   MOD_RES         103
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y508"
FT   MOD_RES         113
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y508"
SQ   SEQUENCE   229 AA;  25745 MW;  7E500B9687EA0DD8 CRC64;
     MAAAQPESRD GAAQSAKPAS ETDPLSRFTC PVCLEVFEKP VQVPCGHVFC SACLQECLKP
     KKPVCGVCRS ALAPGVRAVE LERQIESIET SCHGCRKNFI LSKIRAHVTS CSKYQNYIME
     GVKATTKDAS LQPRNIPNRY TFPCPYCPEK NFDQEGLVEH CKLTHSTDTK SVVCPICASM
     PWGDPSYRSA NFMEHIQRRH RFSYDTFVDY DVDEDDMINQ VLQRSIIDQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024